• Route

  • Cluster question

  • Organisation

Research initiatives

PM.20.045 – Next generation immunodermatology

Route: Personalised medicine: the individual at the centre

cluster question: 095 How can we personalise health care, for example by using biomarkers?

Until recently, Dermatology has been neglected from therapeutics development resulting in a high unmet need for many skin diseases. As […]

View the initiative

PM.20.047 – 4D skeletal surgery twin

Route: Personalised medicine: the individual at the centre

cluster question: 095 How can we personalise health care, for example by using biomarkers?

The project ‘4D skeletal surgery twin’ aims at the improvement of personalized skeletal health. Degenerative diseases such as cancer, rheumatic […]

View the initiative

PM.20.050 – A computer simulation approach to enhance the pacemaker lead implantation in a patient specific fashion

Route: Personalised medicine: the individual at the centre

cluster question: 088 How can we predict, prevent, and treat cardiovascular diseases (atherosclerosis, heart failure, heart arrhythmia, and thrombosis) in individuals at an early stage?

A computer simulation approach to enhance the pacemaker lead implantation in a patient specific fashionCardiovascular disease are the number 1 […]

View the initiative

PM.20.052 – Personalized medicine in osteoarthritis

Route: Personalised medicine: the individual at the centre

cluster question: 101 Can we model the human body and use smart technologies for health, nutritional, and toxicity research, drastically reducing the use of laboratory animals at the same time?

Osteoarthritis is one of the most common chronic diseases characterized by gradual joint deterioration. The disease presentation is highly variable […]

View the initiative

PM.20.035 – MINNIE Model-INformed dosiNg in chIldrEn: best pharmacotherapy for every child

Route: Personalised medicine: the individual at the centre

cluster question: 101 Can we model the human body and use smart technologies for health, nutritional, and toxicity research, drastically reducing the use of laboratory animals at the same time?

Even today, approximately 50% of all drugs prescribed to children are off-label. Pediatric efficacy and safety data are lacking to […]

View the initiative